Ignacio Garrido‐Laguna

University of Utah

Full Professor(heuristic)

Pancreatic and Hepatic Oncology Research · Oncology

Compare more Oncology professors.

h-index42
i10-index110
Publications358
Citations14,275

Grants

2 total · 0 active

NIH #UM1CA186712

The Ohio State University as a Lead Academic Organization (LAO) for the Experimental Therapeutics Clinical Trials Network

Amount
$5M–$6M
Period
2014-03-282023-02-28
PIs
3

Awarded at OHIO STATE UNIVERSITY

NIH #R21CA182977

Multi-Tracer PET/CT Imaging of Gemcitabine Response in Pancreatic Cancer

Amount
$300K–$400K
Period
2014-09-152017-04-30
PIs
2

Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

2 total · 0 active

NIH #UM1CA186712

The Ohio State University as a Lead Academic Organization (LAO) for the Experimental Therapeutics Clinical Trials Network

Amount
$5M–$6M
Period
2014-03-282023-02-28
PIs
3

Awarded at OHIO STATE UNIVERSITY

NIH #R21CA182977

Multi-Tracer PET/CT Imaging of Gemcitabine Response in Pancreatic Cancer

Amount
$300K–$400K
Period
2014-09-152017-04-30
PIs
2

Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH

Recent Public Signals

  1. New paper: Supplementary Data 1 from Comparative Genomic Analysis of Pancreatic Acinar Cell Carcinoma (PACC) and Pancreatic Ductal Adenocarcinoma (PDAC) Unveils New Actionable Genomic Aberrations in PACC2025-11-25
  2. New preprint: Mechanisms of resistance to active state selective tri-complex RAS inhibitors2025-04-26

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-09-04

Data may not be current

Find elsewhere

ORCID: 0000-0003-2273-9028

Professor Insights

Career Trajectory